Mark Hancock sold $7.3M of PACS
Co-Founder & Exec. Vice Chair. at PACS Group, Inc.. 161,068 shares at an average of $45.30, traded Jul 1, 2026, filed Jul 6, 2026.
Score components
- +15RoleDirector
- +25Trade size$7.3M at market
- 0Share of holdings soldSold 0.3% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002014361-26-000022, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | AGrant or award Common Stock10b5-1 | +4,287 | $0.00 | $0 | 54,106,884 | Jul 6, 2026 |
| Jul 1, 2026 | SOpen-market sale Common Stock10b5-1 | -6,080 | $45.02 | $274k | 54,100,804 | Jul 6, 2026 |
| Jul 2, 2026 | SOpen-market sale Common Stock10b5-1 | -12,825 | $45.01 | $577k | 54,087,979 | Jul 6, 2026 |
| Jul 6, 2026 | SOpen-market sale Common Stock10b5-1 | -142,163 | $45.33 | $6.4M | 53,945,816 | Jul 6, 2026 |
Related signals
Other insiders at PACS Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $1.6M 36,692 shares | -0% | |
| 30Weak | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $3.5M 83,308 shares | -0% | |
| 40Moderate | PACS Group, Inc. | Joshua Jergensen President & COO | $1.7M 40,000 shares | -2% | |
| 35Weak | PACS Group, Inc. | Mark Hancock Co-Founder & Exec. Vice Chair. | $13M 300,000 shares | -1% | |
| 43Moderate | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $887k 19,617 shares | -0% | |
| 45Moderate | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $2.2M 51,887 shares | -0% | |
| 38Weak | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $2.9M 68,113 shares | -0% | |
| 51Moderate | PACS Group, Inc. | Patrick Hugh Conway director | $155k 3,497 shares | -28% | |
| 45Moderate | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $6.6M 150,550 shares | -0% | |
| 45Moderate | PACS Group, Inc. | Jason Hulse Murray Co-Founder, CEO & Chairman | $10M 236,116 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.